Psychedelics Optimi Health gets psychedelics import permit for Mind Medicine Australia shipment BC's mushroom expert got an MDMA export permit for shipments to Israel this month too Rowan DunneMay 31, 2024
Psychedelics New survey aims to gather data on psychedelic use worldwide The survey running until June 2 is sponsored by MAPS, Mind Medicine Australia, SABI Mind and Tiny Rowan DunneMay 23, 2023
News Mind Medicine Australia to supply medical psilocybin and MDMA for clinical trials at no cost It is particularly interested in supporting research that optimizes treatment results and extends the application of psychedelic-assisted therapies Natalia Buendia CalvilloMay 18, 2023
Psychedelics Optimi Health secures MDMA and psilocybin distribution agreement in Australia The company will supply Mind Medicine Australia with the substances, now considered designated therapies in the country Rowan DunneMarch 1, 2023
International Mind Medicine Australia receives AUD$1M grant for psychedelic research New fund will support studies on psychedelic-assisted therapies for the treatment of mental health conditions Rowan DunneAugust 23, 2022
Industry update Australia to spend $14.5M on psychedelic drug trials Australia is funding research to see if magic mushrooms and ecstasy can treat depression and PTSD Jared GnamMarch 17, 2021